What's Wrong With American Drug Development
at 51:02
Answer
We have a policy to "do no harm," but instead we should be aiming to "do more good." For example, we could use a drug that might kill 2% of the people that take it, but 80% of the people who were otherwise going to die, would not live. That's a much better outcome, but we can't do it right now due to regulations.
We have the science and the manufacturing capacity to do it, but regulatory hurdles in America are preventing scientists from actually doing it. As a result, people do not have a choice to decide whether they want to use a certain drug or not.
Even Remdesivir, the drug that seems to be helping with Covid-19 and does not have any mortality associated with it, people cannot simply get it at the hospital.
Where this answer comes from
- Show
- All-In
- Episode
- COVID-19 Political, Economic & Social Ramifications
- Date
People
More notes from this episode
- How Did Restaurant Bookings Measure Social Isolation? Transcript
- What Is Wrong With Our Covid-19 Response Strategy Transcript
- Is the Anti-science Reaction New, According to David Friedberg? Transcript
- What Are We Missing With Testing for the Coronavirus Disease Transcript
- Will Coronavirus Be the End of Trump's Presidency Transcript
- Why Is Media So Completely Inaccurate Today Transcript
- Do We Have Any Miracle Drugs to Treat Coronavirus Transcript
- Why Is Italy Having Such a Hard Time With Coronavirus Transcript
- What Is Herd Immunity and Why Is It Important Transcript
- How Is Facebook Similar to the Coronavirus Transcript
- Why Are We All Hiding From the Coronavirus Transcript
- What Can We Do to Improve Our Response to Viral Diseases of the Future Transcript
- What's Wrong With American Drug Development Transcript
- What Are the Unintended Consequences of Coronavirus Lockdown Transcript
- Why Is the Stock Market Crashing Due to the Virus Transcript
- What Is Next for Startups and Venture Capital Transcript
More answers like this
- What Can We Do to Improve Our Response to Viral Diseases of the Future
- What Are the Unintended Consequences of Coronavirus Lockdown
- Why Are We All Hiding From the Coronavirus
- Why Is the Stock Market Crashing Due to the Virus
- Why Are We Seriously Overestimating Covid19 Death Rate
- Why Aren't We Using Experimental Drugs to Cure This Coronavirus
More with Chamath Palihapitiya
- Why Should Anthropic Raise $200 Billion Now?
- How Close Is CoreWeave to Its Breakeven?
- What Default Odds Did CoreWeave's Swaps Imply?
- Why Is Bill Gates the AI Doomer?
- Why Did CoreWeave Bonds Crush the Cloud Stocks?
- Is Software Intellectual Property Now Worthless?
More with Jason Calacanis
- Why Does Ben Horowitz Own Both AI Labs?
- What Leaked From Anthropic's Investor Day?
- Why Did Bill Gates Retire to Be Loved?
- Is the CoreWeave Crash Just Market Volatility?
- Did Jason Calacanis Want Lockdown Policy Judged by Its Side Effects?
- What Makes for a Healthy Work-life Balance
Related episodes
- CoreWeave Crash, AI Trade Cracks, Anthropic IPO Red Flags, Bill Gates Doomer
- COVID-19 & Impact on Startups, Venture Capital & Public Markets
- Dylan Field: Is AI Replacing Designers?, Design is the New Code & Democratizing Creativity
- E291: Trump's Super Intelligence Summit, AI Safety Accord, GDP Beats, Midterm Predictions
- Is Claude Conscious? Pope Rejects, Model Welfare Movement, OpenAI's Math Backlash, France Riots
- Chamath Palihapitiya: People in Silicon Valley are deeply unhappy
- Jason Calacanis: TikTok should be banned, Tim Cook doesn't have enough "chutzpah," and Uber will be fine
- Sun. 03/08 - Italy Locks Down, and Why Aren't We Testing More?